Kodiak Sciences (KOD)
(Delayed Data from NSDQ)
$3.19 USD
-0.20 (-5.77%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $3.18 -0.01 (-0.16%) 5:48 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Price, Consensus and EPS Surprise
KOD 3.19 -0.20(-5.77%)
Will KOD be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for KOD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for KOD
Kodiak (KOD) Counts on Tarcocimab Program Despite Setbacks
Kodiak (KOD) Stock Falls on Q4 Earnings Miss, Pipeline in Focus
KOD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Take the Zacks Approach to Beat the Market: NVIDIA, Dell, Modine in Focus
Merck (MRK) Unit to Buy Elanco's Aqua Business for $1.3B
Vertex's (VRTX) Q4 Earnings and Sales Surpass Estimates
Other News for KOD
BGC, DRS and AMTX are among after hour movers
Kodiak Sciences price target raised by $2 at UBS, here's why
12 Health Care Stocks Moving In Wednesday's After-Market Session
Commit To Purchase Kodiak Sciences At $1.50, Earn 10% Using Options
Kodiak Sciences price target raised by $1 at Barclays, here's why